The human microbiome and its expanding role in health and pharmacology

Ashvini Arun Kakad^1*, Rucha A Ingle¹, Aarti Mahadev Nimse¹, Rutuja Devidas Giram¹, Shatrughna Uttam Nagrik ¹

Keywords: Microbiome, Gut microbiota, Fecal Microbiota Transplantation, Microbiome Therapeutics

DOI: 10.18231/j.yjom.2024.020

DOI URL: https://doi.org/10.18231/j.yjom.2024.020

Publish Date: 15-12-2024

Pages: 190 - 196

Views: 21

Downloads: 27

Author Affiliation:

¹Anuradha College of Pharmacy, Chikhali, Puna, Maharashtra, India

Abstract

The broad group of bacteria that live in the human body is called the microbiome. This has recently become an important component of pharmacology, and it offers some of the latest insights into drug processing, effectiveness, and safety. Recent investigations have underlined once again the crosstalk between microbiome and pharmacokinetics: gut microorganisms influence how medications are absorbed, distributed, metabolized, and excreted. The consequences of this relationship in terms of personalized treatment are most relevant because the individual profiles of the microbiome of a person might influence their response to medications and their vulnerability to toxicity. In addition, microbiome manipulation could be used to make care more efficient and diminish adverse effects. It discusses the latest advances in microbiome research, their impact on drug development and clinical practice, and potential future ways in which knowledge regarding the microbiome can be integrated into pharmacological research. This rapidly growing field is promising to transform medication therapy and optimize treatment techniques through the linkage of microbiome science to pharmacology.